IRLA
IRulya Therapeutics Inc.
IRLA | NASDAQ
$33.03
+$0.08 (+0.24%)
At close: Nov 2, 2026, 3:59 PM ET
$32.95
$0.00 (0.00%)
Pre-market:
Nov 2, 2026, 8:26 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -75.49M | 35.91M | -39.46M | -13.44M | -16.05M | -15.03M | -12.46M | -5.49M | -27.73M | -11.15M | -8.89M | -5.35M | -4.89M | -12.25M | -5.53M | -7.92M | -16.56M | -21.64M | -23.4M | -21.71M | -21.75M | -23.09M |
Depreciation & Amortization | 41K | 36K | 39K | 36K | 35K | 32K | 16K | 86K | 44K | 40K | 304K | n/a | 1K | 17K | 42K | 40K | 84K | 38K | 84K | 87K | 87K | 86K |
Stock-Based Compensation | 12.09M | 1.29M | 1.19M | 1.26M | 1.27M | 1.39M | 1.13M | 1.12M | 1.22M | 1.27M | 1.09M | 1.33M | 1.32M | 1.48M | 1.63M | 694K | 5.05M | 9.24M | 8.49M | 7.62M | 6.75M | 6.99M |
Other Working Capital | -7.85M | -20.36M | 13.62M | -1.44M | -433K | 2.03M | 544K | 673K | -1.76M | -864K | 377K | -134K | 1.5M | 524K | -1.15M | 384K | -434K | -2.68M | -1.83M | 723K | -7.33M | 2.82M |
Other Non-Cash Items | 52.05M | -30.41M | 15.28M | 2.03M | 5.2M | 1.96M | 1.87M | -2.83M | 19.15M | 2.29M | 3M | -719K | -465K | 5.83M | -208K | 771K | 215K | 135K | 199K | 248K | 336K | 294K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.82M | n/a | n/a | -248K | n/a | n/a | -284K | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -7.59M | -14.45M | 12.47M | 194K | -1.87M | 2.05M | 1.9M | -152K | -1.42M | -805K | 250K | -79K | 201K | 1.61M | -1.77M | -281K | -3.92M | -3.86M | 205K | -3.59M | -2.98M | 2.11M |
Operating Cash Flow | -18.89M | -7.63M | -10.48M | -9.93M | -11.42M | -9.6M | -7.55M | -7.26M | -8.74M | -8.35M | -6.08M | -4.82M | -3.83M | -3.57M | -5.84M | -6.7M | -15.42M | -16.09M | -14.42M | -17.34M | -17.56M | -13.61M |
Capital Expenditures | n/a | n/a | -4K | -74K | -126K | -148K | -133K | -46K | -39K | -39K | -24K | n/a | n/a | -136K | -78K | -50K | n/a | -5K | -44K | n/a | -99K | -37K |
Cash Acquisitions | 8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.12M | n/a | n/a | n/a | n/a | n/a | n/a | 135K | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | -4.92M | -15.71M | -11.84M | -1.95M | n/a | -3.84M | -46.43M | -39.29M | -18.67M | -44.99M | -42.44M | -7.69M | -8.25M | -29.92M | -27.89M | -8.96M | -3.01M | -10.61M | -13.19M | -11.98M |
Sales Maturities Of Investments | -62K | 12M | 13M | 14M | 18M | 12.65M | 10.51M | 10.99M | 41.49M | 48.25M | 26.7M | 49.12M | 22.12M | 13.28M | 27M | 21.11M | 12.01M | 22.38M | 23.97M | 11.38M | 18.91M | 43.66M |
Other Investing Acitivies | 62K | n/a | n/a | n/a | n/a | 355K | 490K | n/a | n/a | n/a | -500K | -500K | n/a | 90K | n/a | 35K | 10.63M | -135K | n/a | n/a | n/a | n/a |
Investing Cash Flow | 8M | 12M | 8.07M | -1.78M | 6.04M | 10.9M | 10.87M | 7.11M | -4.98M | 8.91M | 5.39M | 3.64M | -20.32M | 5.54M | 18.67M | -8.83M | -5.25M | 13.41M | 20.92M | 766K | 5.62M | 31.64M |
Debt Repayment | n/a | -5.55M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6K | n/a | n/a | -6K | -18K | -19K | -12K | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -56K | n/a | n/a | n/a | n/a | n/a | n/a | -5M | n/a | n/a | 6K | n/a | n/a | 56K | n/a | 14K | 120K | 14K | n/a | n/a | n/a | n/a |
Financial Cash Flow | 108.93M | 9.44M | 2.03M | 1.38M | 14.41M | 87K | n/a | -5M | 35K | 190K | 57K | 10K | 26K | 50K | -18K | -5K | 108K | 622K | 990K | 4.71M | 672K | 441K |
Net Cash Flow | 97.82M | 12.35M | -643K | -10.37M | 9.06M | 1.56M | 3.54M | -5.22M | -13.92M | 1.06M | -880K | -1.02M | -24.06M | 2.14M | 12.77M | -15.12M | -20.64M | -2.16M | 7.52M | -11.84M | -11.27M | 18.47M |
Free Cash Flow | -18.89M | -7.63M | -10.49M | -10M | -11.54M | -9.75M | -7.69M | -7.31M | -8.78M | -8.39M | -6.1M | -4.82M | -3.83M | -3.71M | -5.91M | -6.75M | -15.42M | -16.1M | -14.46M | -17.34M | -17.66M | -13.65M |
Adj. Free Cash Flow | -30.98M | -8.91M | -11.68M | -11.26M | -12.81M | -11.14M | -8.81M | -8.43M | -10M | -9.67M | -7.19M | -6.15M | -5.15M | -5.19M | -7.55M | -7.44M | -20.47M | -25.34M | -22.96M | -24.96M | -24.41M | -20.64M |
Maintenance CapEx | n/a | n/a | -4K | -36K | -35K | -32K | -16K | -46K | -39K | -39K | -24K | n/a | n/a | -17K | -42K | -40K | n/a | -5K | -44K | n/a | -87K | -37K |
Growth CapEx | n/a | n/a | n/a | -38K | -91K | -116K | -117K | n/a | n/a | n/a | n/a | n/a | n/a | -119K | -36K | -10K | n/a | n/a | n/a | n/a | -12K | n/a |
Owner Earnings | -18.89M | -7.63M | -10.49M | -9.96M | -11.45M | -9.63M | -7.57M | -7.31M | -8.78M | -8.39M | -6.1M | -4.82M | -3.83M | -3.59M | -5.88M | -6.74M | -15.42M | -16.1M | -14.46M | -17.34M | -17.65M | -13.65M |
Add to Watchlist
Select watchlists to add or remove IRLA